
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Insight from Linker Investigations: Discovery of a Novel Phenylbenzothiazole Necroptosis Inhibitor Targeting Receptor-Interacting Protein Kinase 1 (RIPK1) from a Phenoxybenzothiazole Compound with Dual RIPK1/3 Targeting Activity
Jingjie Fang, Houzong Yao, Chunlin Zhuang, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 22, pp. 15288-15308
Closed Access | Times Cited: 5
Jingjie Fang, Houzong Yao, Chunlin Zhuang, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 22, pp. 15288-15308
Closed Access | Times Cited: 5
Showing 5 citing articles:
RIPK1 inhibitors: A key to unlocking the potential of necroptosis in drug development
Yinliang Bai, Yujun Qiao, Mingming Li, et al.
European Journal of Medicinal Chemistry (2024) Vol. 265, pp. 116123-116123
Closed Access | Times Cited: 14
Yinliang Bai, Yujun Qiao, Mingming Li, et al.
European Journal of Medicinal Chemistry (2024) Vol. 265, pp. 116123-116123
Closed Access | Times Cited: 14
Recognition of necroptosis: From molecular mechanisms to detection methods
Ting Zhu, Bowen Wu
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117196-117196
Open Access | Times Cited: 6
Ting Zhu, Bowen Wu
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117196-117196
Open Access | Times Cited: 6
Bardoxolone Derivatives as Novel Pseudo-Natural Necroptosis Inhibitors by Destabilizing HSP90 Client Proteins
Yu Zou, Chai Yue, Bolin Du, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Yu Zou, Chai Yue, Bolin Du, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Design, synthesis, and structure–activity relationship studies of 6,7-dihydro-5H-pyrrolo[1,2-b][1,2,4]triazole derivatives as necroptosis inhibitors
Zechen Jin, Yang Dai, Yinchun Ji, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 7, pp. 2514-2526
Open Access | Times Cited: 1
Zechen Jin, Yang Dai, Yinchun Ji, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 7, pp. 2514-2526
Open Access | Times Cited: 1
From Hit to Lead: Structure-Based Optimization of Novel Selective Inhibitors of Receptor-Interacting Protein Kinase 1 (RIPK1) for the Treatment of Inflammatory Diseases
Liting Zhang, Yueshan Li, Chenyu Tian, et al.
Journal of Medicinal Chemistry (2023) Vol. 67, Iss. 1, pp. 754-773
Closed Access | Times Cited: 3
Liting Zhang, Yueshan Li, Chenyu Tian, et al.
Journal of Medicinal Chemistry (2023) Vol. 67, Iss. 1, pp. 754-773
Closed Access | Times Cited: 3
Discovery of a Novel Benzimidazole Necroptosis Inhibitor from an In-House Compound Library
Yu Zou, Chai Yue, Hongming Shao, et al.
Pharmaceutical Fronts (2024) Vol. 06, Iss. 03, pp. e283-e293
Open Access
Yu Zou, Chai Yue, Hongming Shao, et al.
Pharmaceutical Fronts (2024) Vol. 06, Iss. 03, pp. e283-e293
Open Access